H.I.G. Weighs Sale of $1 Billion Rising Pharmaceuticals Stake

H.I.G. Capital is exploring options for its controlling stake in U.S.-based Rising Pharmaceuticals, including a possible sale, according to Bloomberg. People familiar with the matter said the drugmaker is valued at about $1 billion.